Skip to main content
logo
Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
4.570
-0.190 (-3.99%)
At close: Aug 10, 2026, 4:00 PM EDT
4.560
-0.010 (-0.22%)
After-hours: Aug 10, 2026, 7:59 PM EDT

Clover Health Investments Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-18.36-85.55-43.01-213.36-339.57-587.76
Depreciation & Amortization
1.911.691.332.511.191.25
Stock-Based Compensation
72.38103.66114.33140.93164.31163.72
Other Adjustments
-2.59-2.53-3.069.48-128.1758.45
Change in Receivables
-26.23-43.3312.636.44-22.57-24.38
Changes in Accounts Payable
1.461.65-2.624.747.645.31
Changes in Accrued Expenses
5.97-3.05-1.97-2.98.7811.17
Changes in Other Operating Activities
42.5-39.474.8217.013.7989.91
Operating Cash Flow
77.03-66.9334.85-144.66-203.93-282.33
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.83-2.04-1.56-0.58-4.47-0.72
Purchases of Investments
-213.32-205.1-201.24-175.57-369.4-876.25
Proceeds from Sale of Investments
170.63211.22203.36316.16485.45441.53
Cash Acquisitions
-----16.2-
Other Investing Activities
-----0.25-
Investing Cash Flow
-45.524.080.57140.0195.13-435.45

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
------30.93
Net Long-Term Debt Issued (Repaid)
------30.93
Issuance of Common Stock
3.131.810.91.151.4956.55
Repurchase of Common Stock
-24.45-55.2-18.26-6.22-6.36-0.23
Net Common Stock Issued (Repurchased)
-21.33-53.38-17.36-5.07-4.96956.32
Financing Cash Flow
-21.33-53.38-17.36-5.07-4.96925.39

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
121.94-116.2418.05-9.72-113.76207.62

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
74.21-68.9833.29-145.25-208.39-283.05
Free Cash Flow Growth
------
FCF Margin
3.00%-3.58%2.43%-11.52%-19.00%-19.23%
Free Cash Flow Per Share
0.14-0.130.07-0.30-0.44-0.69
Levered Free Cash Flow
30.65-126.78-43-192.59-322.64-511.77
Unlevered Free Cash Flow
104.35-126.76-45.74-184.56-269.74-530.08
SEC Filings: 10-K · 10-Q